Clinician AI assistant company Navina has raised a $55 million series C funding round, the company announced Tuesday.
The round was led by Growth Equity at Goldman Sachs Alternatives. Former investors Vertex Ventures Israel, Grove Ventures and ALIVE also participated in the round, bringing Navina’s total investment to date to $100 million.
The company raised a $22 million series B in November 2022 and a $15 million series A in October 2021.
Navina’s AI copilot assists clinicians at the point of care by presenting actionable insights on a patient’s health history. Navina’s software aggregates structured and unstructured clinical data to create patient profiles that augment the amount of information clinicians can access at the point of care.
Navina recently partnered with value-based primary care company Agilon to deploy the AI copilot to its 2,800 primary care providers. It also has secured partnerships with InnovaCare Health, Millennium Physician Group and Privia Health. The company also won the 2025 Best in KLAS award for clinician digital workflow.
"We have been seeking a solution to enhance the precision of our coding for interactions with payers in value-based care," Matthew Mossburg, director of population health services at Holzer Health System, said in a statement. "Navina provides the ideal tool to support our physician group in accurately capturing the severity of our patients' conditions, while also improving our risk scoring capabilities. Thus far, Navina's service has been exceptional and seamlessly integrated into our operations. We are confident that this partnership will yield significant, positive outcomes."
The platform supports 3 million patients and 10,000 healthcare professionals across 1,300 clinics, a press release from Navina said. With the investment, the company plans to expand further into the U.S. and enhance its technology.
“This investment is a powerful validation of Navina’s vision to improve patient outcomes and healthcare economics by breaking down data barriers with AI,” Ronen Lavi, cofounder and CEO of Navina, said in a statement. “We’re thrilled to partner with a best-in-class firm like Goldman Sachs, whose market leadership will be instrumental as we enter this pivotal growth phase and expand our market reach. With this additional capital, we will continue to accelerate AI innovation and revolutionize healthcare by making every patient interaction more empathic, personalized, and proactive.”